1-8 of 8
Xian Zhang, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fli-1 Regulates Multiple T-Cell Subsets during Inflammatory Responses and Experimental Graft-Versus-Host Disease

Steven Douglas Schutt, BS, David Bastian, Hee-Jin Choi, PhD, Yongxia Wu, PhD MD, Mohammed Hanief Sofi, PhD MS, Hung Nguyen, PhD, Xian Zhang, PhD, Xue-Zhong Yu, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3201.
https://doi.org/10.1182/blood-2019-127577
Published: 2019
Journal Articles

A Long-Term Retrospective Analysis of Arsenic-Containing Triple-Agents Treatment for Acute Promyelocytic Leukemia (APL) in a Cohort from a Single Hospital

Xian Zhang, PhD, Junfang Yang, MD, Fanyong LV, Gailing Zhang, MD, Yunchao Su, MD, Peihua Lu
Journal: Blood
Blood (2018) 132 (Supplement 1): 4060.
https://doi.org/10.1182/blood-2018-99-117795
Published: 2018
Journal Articles

CD19-CAR-T Therapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Refractory/Relapsed and High Risk B-Cell Acute Lymphoblastic Leukemia

Yanli Zhao, Jianping Zhang, Deyan Liu, Min Xiong, Zhijie Wei, Ruijuan Sun, Jiarui Zhou, Yue Lu, Xingyu Cao, Junfang Yang, MD, Xian Zhang, PhD, Hui Wang, PhD, Hongxing Liu, MD, Peihua Lu, Daopei Lu
Journal: Blood
Blood (2018) 132 (Supplement 1): 2660.
https://doi.org/10.1182/blood-2018-99-118852
Published: 2018
Journal Articles

A Feasibility and Safety Study of CD19 and CD22 Chimeric Antigen Receptors-Modified T Cell Cocktail for Therapy of B Cell Acute Lymphoblastic Leukemia

Junfang Yang, MD, Jianqiang Li, Xian Zhang, PhD, Fanyong LV, Xiaoling Guo, Qinglong Wang, Lin Wang, Dandan Chen, Xiaosu Zhou, Jinhai Ren, MD, Peihua Lu
Journal: Blood
Blood (2018) 132 (Supplement 1): 277.
https://doi.org/10.1182/blood-2018-99-114415
Published: 2018
Journal Articles

Efficacy and Safety of CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphocytic Leukemia (B-cell ALL) in a Large Cohort Including Patients with Extramedullary Disease(EMD), High Leukemia Burden, BCR-ABL (+) Mutation,TP53 Mutation, and Post-Transplant Relapse

Xian Zhang, PhD, Xin-an Lu, Junfang Yang, MD, Fanyong LV, Min Xiong, Jianping Zhang, Xiaosu Zhou, Ting He, Peihua Lu
Journal: Blood
Blood (2018) 132 (Supplement 1): 280.
https://doi.org/10.1182/blood-2018-99-115642
Published: 2018
Journal Articles

A 11-Year Clinical Summary of DC - CIK / NK Cell Immunotherapy for 152 Patients with Acute Myeloid Leukemia

Xian Zhang, PhD, Junfang Yang, MD, Gailing Zhang, MD, Peggy (Pei-Hua) Lu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1369.
https://doi.org/10.1182/blood.V130.Suppl_1.1369.1369
Published: 2017
Journal Articles

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Biping Deng, MD, Alex Hongsheng Chang, Professor, Junfang Yang, MD, Jing Pan, MD, Xian Zhang, PhD, Yuehui Lin, MD, Yanan Wu, MD, Zhenling Deng, PhD, Peihua Lu, MD, Tong Wu, MD, Zhaoli Liu, Bachelor, Yu'e Zhang, Bachelor, Chunrong Tong, MD
Journal: Blood
Blood (2016) 128 (22): 649.
https://doi.org/10.1182/blood.V128.22.649.649
Published: 2016
Journal Articles

Lower Dosages of Intravenous Immunoglobulin (IVIg) in Treating Immune Thrombocytopenia with Long-Term Follow-up of Three Years

Zeping Zhou, Sr., MDPhD, Zhuoqing Qiao, MD, Huiyuan Li, PhD, Xian Zhang, PhD, Feng Xue, MDPhD, Renchi Yang, MDPhD
Journal: Blood
Blood (2015) 126 (23): 3480.
https://doi.org/10.1182/blood.V126.23.3480.3480
Published: 2015